Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000424?dgcid=rss_sd_all
Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000424?dgcid=rss_sd_all
“Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma.” Blood Immunology & Cellular Therapy.
@article{article38455,
title = {Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000424?dgcid=rss_sd_all}
}